Search research articles
Contact Us
Filters
Showing results (171-180 of 187) with videos related to
Page
of 19
Sort By:
Cancer
|
August 16, 2012
The addition of low-dose-rate brachytherapy and androgen-deprivation therapy decreases biochemical failure and prostate cancer death compared with dose-escalated external-beam radiation therapy for high-risk prostate cancer
Mark Shilkrut, Gregory S Merrick, P William McLaughlin, et al.
Brachytherapy
|
February 8, 2007
American Brachytherapy Society recommends no change for prostate permanent implant dose prescriptions using iodine-125 or palladium-103
Mark J Rivard, Wayne M Butler, Phillip M Devlin, et al.
American Journal of Clinical Oncology
|
May 19, 2022
ACR-ABS-ASTRO Practice Parameter for Transperineal Permanent Brachytherapy of Prostate Cancer
Nathan H J Bittner, Brett W Cox, Brian Davis, et al.
Brachytherapy
|
December 14, 2005
Variability of prostate brachytherapy pre-implant dosimetry: a multi-institutional analysis
Gregory S Merrick, Wayne M Butler, Kent E Wallner, et al.
American Journal of Clinical Oncology
|
November 22, 2011
ACR Appropriateness Criteria® definitive external beam irradiation in stage T1 and T2 prostate cancer
Brian J Moran, Paul DeRose, I-Chow Joe Hsu, et al.
Brachytherapy
|
January 24, 2012
American Brachytherapy Society consensus guidelines for transrectal ultrasound-guided permanent prostate brachytherapy
Brian J Davis, Eric M Horwitz, W Robert Lee, et al.
Oncology (Williston Park, N.Y.)
|
December 17, 2014
ACR appropriateness Criteria® Postradical prostatectomy irradiation in prostate cancer
Gary S Gustafson, Paul L Nguyen, Dean G Assimos, et al.
Brachytherapy
|
September 12, 2021
Low dose rate brachytherapy for primary treatment of localized prostate cancer: A systemic review and executive summary of an evidence-based consensus statement
Martin T King, Mira Keyes, Steven J Frank, et al.
Brachytherapy
|
February 8, 2007
Interstitial implant alone or in combination with external beam radiation therapy for intermediate-risk prostate cancer: a survey of practice patterns in the United States
Steven J Frank, Peter D Grimm, John E Sylvester, et al.
International Journal of Radiation Oncology, Biology, Physics
|
July 7, 2018
Clinical Outcomes for Patients With Gleason Score 10 Prostate Adenocarcinoma: Results From a Multi-institutional Consortium Study
Kiri A Sandler, Ryan R Cook, Jay P Ciezki, et al.
Page
of 19
Search research articles
Search
Showing results (171-180 of 187) with videos related to
Sort By:
Page
of 19
Cancer
|
August 16, 2012
The addition of low-dose-rate brachytherapy and androgen-deprivation therapy decreases biochemical failure and prostate cancer death compared with dose-escalated external-beam radiation therapy for high-risk prostate cancer
Mark Shilkrut, Gregory S Merrick, P William McLaughlin, et al.
Brachytherapy
|
February 8, 2007
American Brachytherapy Society recommends no change for prostate permanent implant dose prescriptions using iodine-125 or palladium-103
Mark J Rivard, Wayne M Butler, Phillip M Devlin, et al.
American Journal of Clinical Oncology
|
May 19, 2022
ACR-ABS-ASTRO Practice Parameter for Transperineal Permanent Brachytherapy of Prostate Cancer
Nathan H J Bittner, Brett W Cox, Brian Davis, et al.
Brachytherapy
|
December 14, 2005
Variability of prostate brachytherapy pre-implant dosimetry: a multi-institutional analysis
Gregory S Merrick, Wayne M Butler, Kent E Wallner, et al.
American Journal of Clinical Oncology
|
November 22, 2011
ACR Appropriateness Criteria® definitive external beam irradiation in stage T1 and T2 prostate cancer
Brian J Moran, Paul DeRose, I-Chow Joe Hsu, et al.
Brachytherapy
|
January 24, 2012
American Brachytherapy Society consensus guidelines for transrectal ultrasound-guided permanent prostate brachytherapy
Brian J Davis, Eric M Horwitz, W Robert Lee, et al.
Oncology (Williston Park, N.Y.)
|
December 17, 2014
ACR appropriateness Criteria® Postradical prostatectomy irradiation in prostate cancer
Gary S Gustafson, Paul L Nguyen, Dean G Assimos, et al.
Brachytherapy
|
September 12, 2021
Low dose rate brachytherapy for primary treatment of localized prostate cancer: A systemic review and executive summary of an evidence-based consensus statement
Martin T King, Mira Keyes, Steven J Frank, et al.
Brachytherapy
|
February 8, 2007
Interstitial implant alone or in combination with external beam radiation therapy for intermediate-risk prostate cancer: a survey of practice patterns in the United States
Steven J Frank, Peter D Grimm, John E Sylvester, et al.
International Journal of Radiation Oncology, Biology, Physics
|
July 7, 2018
Clinical Outcomes for Patients With Gleason Score 10 Prostate Adenocarcinoma: Results From a Multi-institutional Consortium Study
Kiri A Sandler, Ryan R Cook, Jay P Ciezki, et al.
Page
of 19